FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma, Inc. | 70092-435 | 70092-435-46 | Acetaminophen 10 mg/ml 10 ml syr PF | Acetaminophen 10 mg/ml 10 ml syr PF | 100 mg/10 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-004 | 70092-004-37 | Amiodarone 450mg add to 250ml D5W IVB | Amiodarone 450mg add to 250ml D5W IVB | 450 mg/250 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-005 | 70092-005-38 | Amiodarone 900mg add to 500ml D5W IVB | Amiodarone 900mg add to 500ml D5W IVB | 900 mg/500 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-229 | 70092-229-43 | Atropine 0.4 mg/ml 2.5 ml- 3 ml syr | Atropine 0.4 mg/ml 2.5 ml- 3 ml syr | 1 mg/2.5 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-475 | 70092-475-50 | Dextrose PF 500mg/ml 50ml SWFI syr | Dextrose PF 500mg/ml 50ml SWFI syr | 25 g/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-575 | 70092-575-36 | Diltiazem PF 125mg in 125ml D5W IVB | Diltiazem PF 125mg in 125ml D5W IVB | 125 mg/125 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-007 | 70092-007-36 | Diltiazem PF 125mg in 125ml D5W IVB | Diltiazem PF 125mg in 125ml D5W IVB | 125 mg/125 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-688 | 70092-688-46 | Epinephrine 10 mcg/ml in 10 ml D5W syr | Epinephrine 10 mcg/ml in 10 ml D5W syr | 100 ug/10 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-103 | 70092-103-36 | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | 200 ug/100 mL; 100 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-160 | 70092-160-37 | Fent 2 mcg/ml-Bup 0.1% PF 250 ml NS IVB | Fent 2 mcg/ml-Bup 0.1% PF 250 ml NS IVB | 500 ug/250 mL; 250 mg/250 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-104 | 70092-104-36 | Fent 2 mcg/ml-Bup 0.125% PF 100ml NS IVB | Fent 2 mcg/ml-Bup 0.125% PF 100ml NS IVB | 200 ug/100 mL; 125 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-105 | 70092-105-37 | Fent 2 mcg/ml-Bup 0.125% PF 250ml NS IVB | Fent 2 mcg/ml-Bup 0.125% PF 250ml NS IVB | 500 ug/250 mL; 312.5 mg/250 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-108 | 70092-108-36 | Fent 2 mcg/ml-Ropiv 0.2% PF 100ml NS IVB | Fent 2 mcg/ml-Ropiv 0.2% PF 100ml NS IVB | 200 ug/100 mL; 200 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-269 | 70092-269-37 | Fent 2 mcg/mlBup 0.0625% PF 250ml NS IVB | Fent 2 mcg/mlBup 0.0625% PF 250ml NS IVB | 156.25 mg/250 mL; 500 ug/250 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-255 | 70092-255-75 | Fent 2mcg/mL-Bup 0.1%PF100mlNS CADDYFSFF | Fent 2mcg/mL-Bup 0.1%PF100mlNS CADDYFSFF | 200 ug/100 mL; 100 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-202 | 70092-202-75 | Fent 2mcg/mL-Bup 0.125%PF100mlNS CADDYFS | Fent 2mcg/mL-Bup 0.125%PF100mlNS CADDYFS | 200 ug/100 mL; 125 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-259 | 70092-259-75 | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADDYFS | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADDYFS | 200 mg/100 mL; 200 ug/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-250 | 70092-250-75 | Fent PF10 mcg/ml 100 ml NS CADD- C FSFF | Fent PF10 mcg/ml 100 ml NS CADD- C FSFF | 1 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-441 | 70092-441-76 | Fent2mcg/mL-Rop0.1% PF200mlNS CADD-YFSFF | Fent2mcg/mL-Rop0.1% PF200mlNS CADD-YFSFF | 400 ug/200 mL; 200 mg/200 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-440 | 70092-440-76 | Fent2mcg/mL-Rop0.2% PF200mlNS CADD-YFSFF | Fent2mcg/mL-Rop0.2% PF200mlNS CADD-YFSFF | 400 mg/200 mL; 400 ug/200 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-207 | 70092-207-37 | Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB | Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB | 400 ug/200 mL; 200 mg/200 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-092 | 70092-092-36 | Fentanyl PF 10 mcg/ml in 100 ml NS IVB | Fentanyl PF 10 mcg/ml in 100 ml NS IVB | 1 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-093 | 70092-093-37 | Fentanyl PF 10 mcg/ml in 250 ml NS IVB | Fentanyl PF 10 mcg/ml in 250 ml NS IVB | 2500 ug/250 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-694 | 70092-694-43 | Fentanyl PF 10mcg/mL in NS 1mL-3mL syr | Fentanyl PF 10mcg/mL in NS 1mL-3mL syr | 10 ug/1 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-094 | 70092-094-36 | Fentanyl PF 20 mcg/ml in 100 ml NS IVB | Fentanyl PF 20 mcg/ml in 100 ml NS IVB | 2 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-444 | 70092-444-05 | Fentanyl PF 5 mcg/ml in 250 ml NS bag | Fentanyl PF 5 mcg/ml in 250 ml NS bag | 1250 ug/250 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-100 | 70092-100-50 | Fentanyl PF 50 mcg/ml 55 ml- 60 ml syr | Fentanyl PF 50 mcg/ml 55 ml- 60 ml syr | 2750 ug/55 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-097 | 70092-097-43 | Fentanyl PF 50 mcg/ml 2ml- 3 ml syr | Fentanyl PF 50 mcg/ml 2ml- 3 ml syr | 100 ug/2 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-099 | 70092-099-49 | Fentanyl PF 50 mcg/ml 30 ml- 35 ml MB | Fentanyl PF 50 mcg/ml 30 ml- 35 ml MB | 1500 ug/30 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-098 | 70092-098-44 | Fentanyl PF 50 mcg/ml 5 ml syr | Fentanyl PF 50 mcg/ml 5 ml syr | 250 ug/5 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-664 | 70092-664-74 | Fentanyl PF 50 mcg/ml 50 ml CADD FSFF | Fentanyl PF 50 mcg/ml 50 ml CADD FSFF | 2500 ug/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-509 | 70092-509-35 | Fentanyl PF 50 mcg/ml 50ml IVB | Fentanyl PF 50 mcg/ml 50ml IVB | 2500 ug/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-281 | 70092-281-08 | Hep 30,000 U add to 1000 ml NS bag | Hep 30,000 U add to 1000 ml NS bag | 30000 U/1000 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-217 | 70092-217-47 | Heparin 1 U/ml 20 ml NS syringe PF | Heparin 1 U/ml 20 ml NS syringe PF | 20 U/20 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-216 | 70092-216-50 | Heparin 1 U/ml 50 ml NS syr PF | Heparin 1 U/ml 50 ml NS syr PF | 50 U/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-114 | 70092-114-50 | Hydromorph PF 0.2 mg/ml 50ml NS syr | Hydromorph PF 0.2 mg/ml 50ml NS syr | 10 mg/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-115 | 70092-115-36 | Hydromorph PF 0.2 mg/ml in 100 ml NS IVB | Hydromorph PF 0.2 mg/ml in 100 ml NS IVB | 20 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-111 | 70092-111-48 | Hydromorph PF 0.2 mg/ml in 30ml NS syr | Hydromorph PF 0.2 mg/ml in 30ml NS syr | 6 mg/30 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-287 | 70092-287-35 | Hydromorph PF 0.2 mg/ml in 50 ml NS IVB | Hydromorph PF 0.2 mg/ml in 50 ml NS IVB | 10 mg/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-290 | 70092-290-49 | Hydromorph PF 0.5 mg/ml 30ml NS-35 ml MB | Hydromorph PF 0.5 mg/ml 30ml NS-35 ml MB | 15 mg/30 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-118 | 70092-118-50 | Hydromorph PF 1 mg/ml 50 ml NS | Hydromorph PF 1 mg/ml 50 ml NS | 50 mg/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-294 | 70092-294-74 | Hydromorph PF 1 mg/ml 50ml NS CADD FSFF | Hydromorph PF 1 mg/ml 50ml NS CADD FSFF | 50 mg/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-546 | 70092-546-35 | Hydromorph PF 1 mg/ml in 50 ml NS IVB | Hydromorph PF 1 mg/ml in 50 ml NS IVB | 50 mg/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-116 | 70092-116-75 | Hydromorph PF0.2 mg/ml 100ml NS CADD | Hydromorph PF0.2 mg/ml 100ml NS CADD | 20 mg/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-293 | 70092-293-49 | Hydromorph PF1 mg/ml 30ml NS-35 ml MB | Hydromorph PF1 mg/ml 30ml NS-35 ml MB | 30 mg/30 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-286 | 70092-286-74 | HydromorphPF 0.2 mg/ml 50ml NS CADDFSFF | HydromorphPF 0.2 mg/ml 50ml NS CADDFSFF | 10 mg/50 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-147 | 70092-147-03 | KCl 10 mEq lido 10 mg add 100 ml NS bag | KCl 10 mEq lido 10 mg add 100 ml NS bag | 10 mg/100 mL; 10 meq/100 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-563 | 70092-563-43 | Ketamine 10 mg/ml in 2 ml NS- 3 ml syr | Ketamine 10 mg/ml in 2 ml NS- 3 ml syr | 20 mg/2 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-119 | 70092-119-44 | Ketamine 10 mg/ml in 5ml NS syr | Ketamine 10 mg/ml in 5ml NS syr | 50 mg/5 mL | 2026-1 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-120 | 70092-120-43 | Ketamine 50 mg/ml 1 ml- 3 ml syr | Ketamine 50 mg/ml 1 ml- 3 ml syr | 50 mg/1 mL | 2026-1 | valid | 2026-09-18 |